Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.

about

Autoimmune enteropathies.Risk of immune-related colitis with PD-1/PD-L1 inhibitors vs chemotherapy in solid tumors: systems assessment.Clinical assessment of immune-related adverse events.

P2860

Q46615815-DC688751-C67A-44F9-B219-05EEDCA69813 Q53818892-A4744A88-BEBC-400A-83B7-C39F1CFBCDC2 Q55292659-10FBA55C-D181-41EA-B7B2-534BD3A06F6A

P2860

Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.

Item

http://www.wikidata.org/entity/Q53723979

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Colon Immune-Related Adverse E ...... t Immunopathological Entities.

@en

Colon Immune-Related Adverse E ...... t Immunopathological Entities.

@nl

type

Item

label

Colon Immune-Related Adverse E ...... t Immunopathological Entities.

@en

Colon Immune-Related Adverse E ...... t Immunopathological Entities.

@nl

prefLabel

Colon Immune-Related Adverse E ...... t Immunopathological Entities.

@en

Colon Immune-Related Adverse E ...... t Immunopathological Entities.

@nl

P1476

Colon Immune-Related Adverse E ...... t Immunopathological Entities.

@en

P2093

Antoine Racine

http://www.w3.org/2001/XMLSchema#string

Caroline Robert

http://www.w3.org/2001/XMLSchema#string

Charlotte Mussini

http://www.w3.org/2001/XMLSchema#string

Christine Mateus

http://www.w3.org/2001/XMLSchema#string

Clélia Coutzac

http://www.w3.org/2001/XMLSchema#string

David Planchard

http://www.w3.org/2001/XMLSchema#string

Emilie Soularue

http://www.w3.org/2001/XMLSchema#string

Franck Carbonnel

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Scoazec

http://www.w3.org/2001/XMLSchema#string

Julien Adam

http://www.w3.org/2001/XMLSchema#string

P2860

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

Pembrolizumab for the treatment of non-small-cell lung cancer

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper.

Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.

P304

1238-1246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ECCO-JCC/JJX081

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Robert

Patricia Lepage

Karim Fizazi

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28967957

http://www.w3.org/2001/XMLSchema#string

Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.

about

P2860

P2860

Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698